Pfizer’s $15 Billion Opportunity
Oct 10, 2017 ·
15m 11s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Pfizer is considering selling its consumer healthcare business. Would Advil, Chapstick and Centrum vitamins fetch a price tag of $15 billion? Industry Focus host Kristine Harjes analyzes the opportunity for...
show more
Pfizer is considering selling its consumer healthcare business. Would Advil, Chapstick and Centrum vitamins fetch a price tag of $15 billion? Industry Focus host Kristine Harjes analyzes the opportunity for Pfizer and its shareholders. We also discuss her recent trip to Greece and it has her thinking about Square. Plus, Kristine offers an earnings preview of Johnson & Johnson and advice for travelers to Greece. Thanks to Slack for supporting The Motley Fool. Slack: Where work happens. Find out why at slack.com
show less
Information
| Author | The Motley Fool |
| Organization | The Motley Fool |
| Website | - |
| Tags |
Copyright 2026 - Spreaker Inc. an iHeartMedia Company
Comments